In vitro studies demonstrated CIK with anti-CD33 or anti-CD123 had equal AML cytotoxic effects; however, CD123-CAR had a safer toxicity profile toward progenitor cells (93). The gene discussed is CD33; the disease is acute myeloid leukemia.